Judy Glynn

Judy Glynn is senior principal scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D

Articles by Judy Glynn

Advances in Monoclonal Antibody Purification

ByJay Wealand,Brian Chen,Erin Miller-Cary,Denis Boyle, PhD,Judy Glynn,Paul Mensah, PhD

March 2nd 2010

New technologies and adaptations of existing technologies can improve platform processes.

The Development and Application of a Monoclonal Antibody Purification Platform

ByPaul Johnson,Judy Glynn,Kristin Thomas,Natarajan Ramasubramanyan, PhD,Paul Mensah, PhD,Timothy Hagerty,Gopinath Annathur,Timothy Pabst, PhD

October 2nd 2009

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.

The Development and Application of a Monoclonal Antibody Purification Platform

ByPaul Johnson,Judy Glynn,Kristin Thomas,Natarajan Ramasubramanyan, PhD,Paul Mensah, PhD,Timothy Hagerty,Gopinath Annathur,Timothy Pabst, PhD

March 2nd 2009

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.

Process-Scale Precipitation of Impurities in Mammalian Cell Culture Broth

ByJudy Glynn

March 2nd 2008

If certain engineering challenges can be addressed, precipitation may prove to be a valuable tool for antibody purification.

Latest Updated Articles

Advances in Monoclonal Antibody Purification
March 2nd 2010
The Development and Application of a Monoclonal Antibody Purification Platform
October 2nd 2009
The Development and Application of a Monoclonal Antibody Purification Platform
March 2nd 2009
Process-Scale Precipitation of Impurities in Mammalian Cell Culture Broth
March 2nd 2008